Markets
Hello September with alarm clock on wooden background
(Getty Images)
back to red

The September stock market scaries reared their head on day 1 — will the pattern hold?

September has statistically been the stock market’s weakest month, across decades and even across borders.

Hyunsoo Rim
9/3/25 6:53AM

When Green Day sang “Wake Me Up When September Ends” in 2004, they were obviously talking about the stock market anomaly that’s bugged researchers and investors for years: that the ninth month of our calendars has statistically been the stock markets weakest, across decades and even borders.

With day 1 of September 2025 now in the books, the month might already be living up to its reputation, as the S&P 500 slipped 0.7% on Tuesday, dragged lower by high-flying AI names hitting the brakes.

Indeed, over the past 45 years, September has been the only month when the S&P 500 Index has averaged a loss. While it’s one thing to know September is weak on average, it’s another to see how often the month really goes south.

In the last decade alone, six Septembers have ended in the red, with four of the past five being especially rough. That includes a 9.3% plunge in 2022 — deeper than the drop seen in 2008 — when the Fed’s aggressive rate-hiking campaign in a bid to quell surging postpandemic inflation rattled investors.

Why September tends to be weak is maddening. Intuitively, it shouldn’t matter what month it is — but the phenomenon has been found to hold back to the 1930s. Various theories have been posited, starting with the seasonal moves that can add to selling pressure. Fund managers, for instance, sometimes clean up their portfolios before fiscal year-end in September and October, while some investors start early on selling losers to shrink their tax bill

One academic study pointed to “post-holiday blues”: when trading slows during summer breaks, bad news isn’t fully priced in, and markets adjust lower once investors return in September. Others have suggested that fewer hours of daylight could affect our moods, or that IPO seasonality could play a role, with bankers bringing more stocks to market after the summer lull to test investor appetite for equities. Pop psychology could add another layer — if many brace for a drop, it could be enough to spark a real drop on any hint of bad news.

And it’s not just on Wall Street: researchers found similar patterns across 47 countries, with average stock returns ~1% lower in the month following major school holidays. In fact, per RBC’s analysis, markets in Canada, the UK, and Hong Kong have all stumbled in September over the past five decades. 

Of course, seasonal influences are only ever going to be very marginal, at most. If the economy roars, inflation cools, AI makes a breakthrough, and geopolitical tensions abate, expect stocks to soar no matter what the calendar says.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.